Holen Sie sich die Stockscreener-App
0.1106
19.50%
0.0183
Schlusskurs vom Vortag:
$0.0923
Offen:
$0.14465
24-Stunden-Volumen:
555.83M
Relative Volume:
27.13
Marktkapitalisierung:
$9.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.21M
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+17.47%
1M Leistung:
+3.86%
6M Leistung:
-96.32%
1J Leistung:
-91.52%
1-Tages-Spanne:
$0.1076
$0.1579
1-Wochen-Bereich:
$0.0826
$0.1579
52-Wochen-Spanne:
$0.0789
$7.83
Conduit Pharmaceuticals Inc Stock (CDT) Company Profile
Firmenname
Conduit Pharmaceuticals Inc
Sektor
Branche
Telefon
(646) 491 9132
Adresse
4851 TAMIAMI TRAIL NORTH, NAPLES
Vergleichen Sie CDT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CDT | 0.11 | 9.30M | 0 | -4.21M | 0 | 0.00 |
| VRTX | 450.44 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 749.43 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.59 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.53 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.84 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Conduit Pharmaceuticals Inc Aktie (CDT) Neueste Nachrichten
What's Going On With Conduit Pharmaceuticals Shares Today? - Benzinga
Stock market today: SCWorx Corp. gains 141.81% while Pyxis Oncology down by 46.41% in early trading - Business Upturn
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders - The Manila Times
Conduit Pharma Secures Key Patent for Autoimmune Drug AZD1656 in Major Japan Market | CDT Stock News - StockTitan
Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - The Malaysian Reserve
Conduit Pharmaceuticals reshuffles board and amends bylaws - Investing.com
Conduit Pharmaceuticals reshuffles board and amends bylaws By Investing.com - Investing.com UK
Conduit Pharmaceuticals Announces Leadership Changes and Bylaws Update - TipRanks
Conduit Pharmaceuticals Strengthens Board with 30-Year Investment Banking Veteran Simon Fry | CDT Stock News - StockTitan
Conduit Pharmaceuticals announces restatement of financials - Investing.com
Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews
Remitly Global Inc (NASDAQ: RELY) Is The Number One Stock Currently Moving. - Stocks Register
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Conduit Pharmaceuticals announces new addition to autoimmune pipeline - Yahoo Finance
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline - StockTitan
Conduit Pharmaceuticals Opens New Lab Space In Cambridge, UK - Contract Pharma
Conduit Pharmaceuticals secures $1.2 million in funding - Investing.com India
Conduit Pharmaceuticals secures $1.2 million in funding By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals announces debt restructuring and additional notes - MSN
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes - The Manila Times
LeMaitre to Participate at Upcoming Investor Conferences in November - The Manila Times
Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements - TipRanks
Lexicon Pharmaceuticals Loses Over A Third Of Its Market Cap Post FDA Vote On Drug: Retail Sentiment Sours - MSN
Prologis Inc (NYSE: PLD): Forecast Strong In 2024, Up 18.49% - Stocks Register
Where Do Analysts Think The Conduit Pharmaceuticals Inc (NASDAQ: CDT) Is Going - Stocks Register
Presidio Property Trust Provides Update on Model Home Activity in Q3 2024 - The Manila Times
Conduit Pharmaceuticals announces debt restructuring By Investing.com - Investing.com Australia
Conduit Pharmaceuticals announces debt restructuring - Investing.com India
CDT Stock on the Rise: A Promising Investment - The InvestChronicle
Conduit Pharmaceuticals Inc [CDT] Insider Nirland Ltd sells 1,500,000 Shares – Insider Selling Alert - Knox Daily
Investing in Capricor Therapeutics Inc (CAPR): What You Must Know - Knox Daily
A stock that deserves closer examination: Conduit Pharmaceuticals Inc (CDT) - US Post News
CDT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Selling Buzz: Conduit Pharmaceuticals Inc [CDT] 10% Owner Nirland Ltd sells 1,500,000 shares of the company - Knox Daily
Astrazeneca PLC Reports 9.9% Passive Stake In Conduit Pharmaceuticals Inc As Of August 7SEC Filing - XM
There is no way Conduit Pharmaceuticals Inc (CDT) can keep these numbers up - SETE News
Conduit Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Ltd Nirland Sells 939,009 Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Stock - Defense World
Conduit Pharmaceuticals insiders sell shares worth over $393k By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals insiders sell shares worth over $393k - Investing.com
Market cap of Conduit Pharmaceuticals Inc [CDT] reaches 9.50M – now what? - The DBT News
Examining Conduit Pharmaceuticals Inc (CDT) more closely is necessary - US Post News
Balance Sheet Dive: Conduit Pharmaceuticals Inc (CDT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Conduit Pharmaceuticals Inc [CDT] Records 50-Day SMA of $0.1531 - Knox Daily
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Conduit Pharmaceuticals executives sell shares worth over $297k By Investing.com - Investing.com Canada
Conduit Pharmaceuticals executives sell shares worth over $297k - Investing.com
Insider Selling: Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Major Shareholder Sells 1,016,823 Shares of Stock - Defense World
Conduit Pharmaceuticals Inc (CDT) expanding its growth trajectory ahead - SETE News
Market cap of Conduit Pharmaceuticals Inc [CDT] reaches 10.18M – now what? - The DBT News
Conduit Pharmaceuticals Inc [CDT] Insider Regan Andrew sells 10,244,392 Shares – Insider Selling Alert - Knox Daily
Finanzdaten der Conduit Pharmaceuticals Inc-Aktie (CDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):